POST (Parliamentary Office of Science and Technology)
Antimicrobial Resistance and Immunisation
A POSTnote that describes the potential for immunisation as a strategy to tackle antimicrobial resistance, both globally and in the UK. It discusses public health priority areas, the role for existing vaccines and the development of new ones.
Antimicrobial resistance (AMR) is an urgent global health threat that, if left unchecked, could account for an estimated 10 million deaths per year by 2050. A report commissioned by the UK Government and published in 2016 concluded that vaccines have been overlooked as a tool to reduce AMR and should be an investment focus.
Immunisation can reduce the AMR burden by preventing infections (including resistant ones) and therefore reducing antibiotic use, a major driver of resistance. This effect has already been seen for vaccines against pneumococcal and influenza infections. There are global differences in vaccine need and the challenges in using immunisation to reduce AMR.
There are two main approaches to this strategy: maximising the utility of existing vaccines by ensuring good uptake and offering them more widely as appropriate, and making decisions about which vaccines should be developed and introduced and when and where to use them most efficiently. Evaluating the impact and cost-effectiveness of a vaccine is an essential step in its use and introduction but how to value a vaccine in the context of AMR is complex and subject to ongoing research.
- Antimicrobial resistance (AMR) has reached a point where some infections may become untreatable.
- Immunisation is one strategy to tackle AMR, by decreasing rates of infection and thereby antibiotic use and preventing the development of resistant infections.
- The World Health Organization has developed a list of pathogens where AMR is of most concern and new antibiotics are needed; there is no equivalent for vaccines.
- Quantifying the impact of immunisation on AMR and incorporating this into calculating the cost-effectiveness of vaccines is still an area of ongoing research.
- Using immunisation to tackle AMR depends on wider use and increased uptake of existing vaccines, and increasing the development of new ones.
POSTnotes are based on literature reviews and interviews with range of stakeholders, and are externally peer reviewed. POST would like to thank interviewees and peer reviewers for kindly giving up their time during the preparation of this briefing, including:
Professor David Livermore, University of East Anglia*
Professor Marc Lipsitch, Harvard TH Chan School of Public Health*
Professor David Salisbury, Centre on Global Health Security, Chatham House*
Professor Andrew Pollard, University of Oxford and Chair of the Joint Committee on Vaccination and Immunisation*
Dr Katie Atkins, Professor John Edmunds, Dr Stefan Flasche and Professor Mark Jit, London School of Hygiene and Tropical Medicine*
Dr Michael Edelstein, Public Health England*
Professor Jeffrey Almond, University of Oxford
Kevin Outterson, Professor of Law, Boston University & Executive Director, CARB-X*
Professor Steve Black, Cincinnati Children's Hospital Medical Centre*
Dr E. David McIntosh, Imperial College London*
Dr Elizabeth Klemm and Dr Zoe Seager, The Wellcome Trust*
Professor Adam Cunningham, University of Birmingham and The BactiVac Network*
Dr Shamez Ladhani, Public Health England*
Department of Health and Social Care*
Dr Martin Friede, World Health Organization
Professor Ben Cooper, Nuffield Department of Medicine, University of Oxford*
Department for International Development*
Dr Marco Cavaleri, European Medicines Agency*
Association of the British Pharmaceutical Industry*
Andrew Earnshaw, Joint Committee on Vaccination and Immunisation
Dr Alberto Giubilini, Oxford Martin School and Wellcome Centre for Ethics and Humanities, University of Oxford
Dr Richard Pebody, Public Health England*
Dr Jonathan Pearce, Medical Research Council*
Dr Padmini Srikantiah, The Gates Foundation*
Professor Rino Rappuoli, GlaxoSmithKline Vaccines and Imperial College London*
*Denotes those who acted as external reviewers of the briefing.
|Academic Fellowships||Upcoming work||POST Publications|
Latest News from
POST (Parliamentary Office of Science and Technology)
Developments in Wind Power28/05/2019 15:51:00
UK power generation from wind has increased in recent years due to sharp reductions in the costs of constructing and operating wind power facilities.
Government responds to Lords Committee report on the Bribery Act 201028/05/2019 14:25:00
The Select Committee on the Bribery Act 2010 receives the Government response to the report: The Bribery Act 2010: post-legislative scrutiny, published on 14 March 2019.
Sustaining the Soil Microbiome21/05/2019 14:25:00
The soil microbiome, communities of microorganisms in soils, underpin natural processes in soil habitats and are affected by environmental and land use change.
Climate Change and Agriculture08/05/2019 14:43:00
Agriculture is highly vulnerable to climate change impacts, which has implications for food security.
Early Interventions to Reduce Violent Crime17/04/2019 14:25:00
Violent crime includes a range of offences, from assault to murder. It can be any action that intentionally inflicts (or threatens) physical or psychological damage.
Advances in Cancer Treatment16/04/2019 16:05:00
A POSTnote that gives an overview of recent advances in cancer treatment, the potential benefits and risks, and considers the opportunities and challenges to using new technologies in the NHS.
Climate Change and Vector-Borne Disease in Humans in the UK11/04/2019 14:43:00
A POST note that summarises the latest data on vector-borne disease in the UK, explores how climate may influence the geographical distribution of species, examines the consequences for public health, and highlights potential adaptation and mitigation strategies.
Chemical Weapons18/03/2019 14:37:00
Chemical weapons are prohibited, however recent chemical weapons attacks in Malaysia, Syria, Iraq and the UK have raised concerns about their use. In the UK in 2018, four people were taken seriously ill and one person died following exposure to a Novichok, a type of nerve agent.
Reservoirs of Antimicrobial Resistance20/02/2019 13:15:00
The widespread use of antimicrobials, particularly antibiotics, has accelerated the spread of antimicrobial resistance (AMR) in microbes. A recent report by the Health and Social Care Committee called for AMR to be a ‘top five policy priority’.